Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.

NCT06458907 is registered in ClinicalTrials.gov with P+F Products + Features USA Inc. as lead sponsor.

NCT NCT06458907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06458907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.
Lead sponsor
P+F Products + Features USA Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
November 30, 2032
Enrollment
780 (estimated)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, heart failure, heart valve diseases, tricuspid valve disease, tricuspid valve insufficiency, tricuspid valve regurgitation